» Articles » PMID: 39409068

Modulatory Effects of Chalcone Thio-Derivatives on NF-κB and STAT3 Signaling Pathways in Hepatocellular Carcinoma Cells: A Study on Selected Active Compounds

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Oct 16
PMID 39409068
Authors
Affiliations
Soon will be listed here.
Abstract

Our previous studies demonstrated the modulatory effects of new synthetic thio-chalcone derivatives in dishes on the Nrf2, NF-κB, and STAT3 signaling pathways in colon cancer cells. This study aimed to evaluate the effect of four selected active chalcone thio-derivatives on the NF-κB and STAT3 signaling pathways involved in inflammatory processes and cell proliferation in human liver cancer cells. Cell survival was assessed for cancer (HepG2) and normal (THLE-2) cell lines. Activation of NF-κB and STAT3 signaling pathways and the expression of proteins controlled by these pathways were estimated by Western blot, and qRT-PCR assessed the expression of NF-κB and STAT3 target genes. We also evaluated the impact on the selected kinases responsible for the phosphorylation of the studied transcription factors by MagneticBead-Based Multiplex Immunoassay. Among the thio-derivatives tested, especially derivatives and , there was an impact on cell viability, cell cycle, apoptosis, and activation of NF-κB and STAT3 pathways in hepatocellular carcinoma (HCC), which confirms the possibilities of using them in combinatorial molecular targeted therapy of HCC. The tested synthetic thio-chalcones exhibit anticancer activity by initiating proapoptotic processes in HCC while showing low toxicity to non-cancerous cells. These findings confirm the possibility of using chalcone thio-derivatives in molecularly targeted combination therapy for HCC.

References
1.
Jing Y, Sun K, Liu W, Sheng D, Zhao S, Gao L . Tumor necrosis factor-α promotes hepatocellular carcinogenesis through the activation of hepatic progenitor cells. Cancer Lett. 2018; 434:22-32. DOI: 10.1016/j.canlet.2018.07.001. View

2.
Krajka-Kuzniak V, Belka M, Papierska K . Targeting STAT3 and NF-κB Signaling Pathways in Cancer Prevention and Treatment: The Role of Chalcones. Cancers (Basel). 2024; 16(6). PMC: 10969505. DOI: 10.3390/cancers16061092. View

3.
Galicia-Moreno M, Silva-Gomez J, Lucano-Landeros S, Santos A, Monroy-Ramirez H, Armendariz-Borunda J . Liver Cancer: Therapeutic Challenges and the Importance of Experimental Models. Can J Gastroenterol Hepatol. 2021; 2021:8837811. PMC: 7937489. DOI: 10.1155/2021/8837811. View

4.
Heudobler D, Rechenmacher M, Luke F, Vogelhuber M, Klobuch S, Thomas S . Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis. Front Pharmacol. 2018; 9:1357. PMC: 6279883. DOI: 10.3389/fphar.2018.01357. View

5.
Alqahtani A, Khan Z, Alloghbi A, Said Ahmed T, Ashraf M, Hammouda D . Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina (Kaunas). 2019; 55(9). PMC: 6780754. DOI: 10.3390/medicina55090526. View